Intravascular clotting syndrome in malaria treated with heparin
Chmielewski, J.; Jaremin, B.; Gandurski, P.
Polski Tygodnik Lekarski 29(16): 667-668
1974
ISSN/ISBN: 0032-3756 PMID: 4827236 Document Number: 77894
Document emailed within 1 workday
Related Documents
Dutkevich, I.G. 2013: Disseminated intravascular clotting (DIC) syndrome in surgical practice Vestnik Khirurgii Imeni I. I. Grekova 172(2): 67-73Jespersen, J. 1981: Acute pancreatitis with disseminated intravascular coagulation treated with heparin and plasma Ugeskrift for Laeger 143(18): 1152-1153
Corrigan, J.J.; Jordan, C.M.; Bennett, B.B. 1973: Disseminated intravascular coagulation in septic shock. Report of three cases not treated with heparin American Journal of Diseases of Children 126(5): 629-632
Barkagan, Z.S.; Momot, A.P.; Glazunova, G.A.; Taranina, T.S.; Koltakova, S.I. 1988: Effect of heparin on fibrinogen formation during experimental toxic syndrome of disseminated intravascular coagulation Ukrainskii Biokhimicheskii Zhurnal 60(1): 23-29
Nakagawa, M. 1993: Heparin, low molecular weight heparin, heparinoid, and antithrombin IIi therapy of disseminated intravascular coagulation Nihon Rinsho. Japanese Journal of Clinical Medicine 51(1): 87-92
Baille, Y.; Blanc, T.; Monties, J.R.; Goudard, A.; Henry, E. 1970: Chronic widespread intravascular coagulation syndrome and cyanotic congenital cardiopathy. the place of heparin during preoperative period La Presse Medicale 78(36): 1571-1574
Gouault-Heilmann, M.; Contant, G.; Pochmalicki, G.; Jan, F. 1984: Disseminated intravascular coagulation induced by heparin. Treatment with a combination of low-molecular weight heparin and concentrated antithrombin IIi Presse Medicale 13(22): 1393-1394
Hemker, H.C.; Kop, J.; Willems, G.M. 1979: Kinetic aspects of the interaction of blood clotting enzymes. VIII. the relation between clotting time and clotting velocity Thrombosis and Haemostasis 41(2): 309-313
Efimov, V.S.; Rozkin, M.I.; Poberiĭ, I.A.; Lindner, D.P. 1981: Effect of regulating blood clotting with heparin and its antagonists on mast cells Farmakologiia i Toksikologiia 44(1): 80-85
Chakrapee-Sirisuk, S.; Amornpichetkul, K.; Visudhiphan, S.; Sangruchi, T.; Srimuninnimit, V.; Sinlarat, P. 2001: Ketoconazole and Flutamide in the treatment of disseminated intravascular clotting from prostate cancer: a case report and review Journal of the Medical Association of Thailand 84(10): 1495-1501
Lerner, R.G.; Goldstein, R.; Cummings, G. 1977: Endotoxin induced disseminated intravascular clotting: evidence that it is mediated by neutrophil production of tissue factor Thrombosis Research 11(2): 253-261
Osoegawa, M.; Motomura, S.; Yamanaka, H.; Tamura, K.; Miyoshi, T. 1999: A successfully treated parkinsonian patient with neuroleptic malignant syndrome complicated by status epilepticus and disseminated intravascular coagulation Rinsho Shinkeigaku 39(6): 653-657
Mäkinen, T.; Tötterman, T.H.; Gordin, A.; Weber, T.H. 1977: Migration inhibition factor and the blood clotting system: effects of defibrination, heparin and thrombin Clinical and Experimental Immunology 29(1): 181-186
Venakatachalapathy, T.S.; Mohan Kumar, S.; Saliba, M.J. 2007: A comparative study of burns treated with topical heparin and without heparin Annals of Burns and Fire Disasters 20(4): 189-198
Akl, B.F.; Vargas, G.M.; Neal, J.; Robillard, J.; Kelly, P. 1980: Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass Journal of Thoracic and Cardiovascular Surgery 79(1): 97-102
Katagiri, H.; Itoh, S.; Uchida, T.; Kawai, Y.; Watanabe, K. 1999: Monitoring of plasma concentration of low molecular weight heparin--comparative evaluation with chromogenic and clotting assays Rinsho Byori. Japanese Journal of Clinical Pathology 47(11): 1046-1051
Chmielewski, J. 1975: The role of blood clotting system and fibrinolysis in tropical malaria Materia Medica Polona. Polish Journal of Medicine and Pharmacy 7(3): 234-236
Beitz, J.M. 2005: Heparin-induced thrombocytopenia syndrome bullous lesions treated with trypsin-balsam of peru-castor oil ointment: a case study Ostomy/Wound Management 51(6): 52
Li, J.; Liu, Z.; Zhang, S.; Shen, Z.; Fan, Z.; Zeng, Y.; Xie, H.; Wang, C.; Jin, X.; Fang, Q.; Zhu, W. 2015: Activated clotting time post therapeutic anticoagulation with unfractionated heparin in patients undergoing elective percutaneous coronary intervention Zhonghua Xin Xue Guan Bing Za Zhi 43(5): 408-412
Patrassi, G.M.; Toffanin, F.; Massa, G.; Schivazappa, L.; Girolami, A. 1979: Short heparin thrombin clotting time, increased fibrinogen and platelet aggregates count in coronary disease: a probable hypercoagulable state Folia Haematologica 106(3): 414-425